Tamoxifen-loaded solid lipid nanoparticles-induced apoptosis in breast cancer cell lines

Journal of Experimental Nanoscience

Volumn 11, Issue 3, 2016, Pages 161-174

  Abbasalipourkabir, Roghayeh ^a   Salehzadeh, Aref ^a   Abdullah, Rasedee ^b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

apoptosis; breast cancer cell lines; solid lipid nanoparticles; tamoxifen

Indexed keywords

CELL CULTURE; CELL DEATH; CYTOLOGY; CYTOTOXICITY; DISEASES; FLOW CYTOMETRY; MORPHOLOGY; NANOPARTICLES;

BREAST CANCER CELLS; HUMAN BREAST CANCER CELLS; INHIBITORY CONCENTRATION; MORPHOLOGICAL CHARACTERISTIC; PHASE-CONTRAST MICROSCOPY; SOLID LIPID NANOPARTICLE (SLN); SOLID LIPID NANOPARTICLES; TAMOXIFEN;

CELLS;

EID: 84949533419     PISSN: 17458080     EISSN: 17458099     Source Type: Journal    
DOI: 10.1080/17458080.2015.1038660     Document Type: Article

References (30)

1. V.A.Fadok Clearance: the last and often forgotten stage of apoptosis. J Mammary Gland Biol Neoplasia. 1999;4:203–211.
2. U.K.Messmer, J.Pfeilschifter New insights into the mechanism for clearance of apoptotic cells. Bio Essays. 2000;22:878–881.
3. G.G.Steel The case against apoptosis. Acta Oncologica. 2001;40:968–975.
4. S.Salami, F.Karami-Tehrani Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. Clin Biochem. 2003;36:247–253.
5. J.Russo, I.H.Russo Mechanisms involved in carcinogenesis of the breast. In: J.R.Pasqualini, editor. Breast cancer. New York, NY: Taylor & Francis; 2002. p. 1–2.
6. G.Fontana, L.Maniscalco, D.Schillaci, G.Cavallaro Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity. Drug Deliv. 2005;12:385–392.
7. F.M.Hashem, M.Nasr, A.Khairy. In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate. Pharm Dev Technol. 2014;19(7):824–832.
8. E.Memisoglu-Bilensoy, I.Vural, A.Bochot, J.M.Renoir, D.Ducheneb, A.AtillaHincal Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity. J Controlled Release. 2005;104:489–496.
9. J.S.Chawla, M.M.Amiji Cellular uptake and concentrations of tamoxifen upon administration in poly(-caprolactone) nanoparticles. Am Assoc Pharm Scientists J. 2003;5:28–34.
10. R.Abbasalipourkabir, A.Salehzadeh, A.RasedeeAbdullah. Antitumor activity of tamoxifen loaded solid lipid nanoparticles on induced mammary tumor gland in Sprague-Dawley rats. Afr J Biotech. 2010;9(43):7337–7345.
11. T.H.Tran, T.Ramasamy, H.J.Cho, Y.I.Kim, B.K.Poudel, H.G.Choi, C.S.Yong, J.O.Kim. Formulation and optimization of raloxifen-loaded solid lipid nanoparticles to enhance oral bioavailability. J Nanosci Nanotechnol. 2014;14(7):4820–4831.
12. H.A.Crissman, J.A.Steinkamp Rapid simultaneous measurement of DNA, protein and cell volume in single cells from large mammalian cell populations. J Cell Biol. 1973;59:766–771.
13. A.Krishan Rapid flow cytofluorometric analysis of cell cycle by propidium iodide staining. J Cell Biol. 1975;6:188–193.
14. K.Hishikava, T.Nakaki, T.Fujii Transformation growth factor-b1 induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells. Eur J Pharmacol. 1999;385:287–290.
15. E.P.Gelman Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: new tricks for an old dog? J Natl Cancer Inst. 1996;88:224–226.
16. L.Serpe, S.Laurora, S.Pizzimenti, E.Ugazio, R.Ponti, R.Canaparo, F.Briatore, G.Barrera, M.R.Gasco, M.G.Bernengo, M.Eandi, G.P.Zara Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells. Anti-Cancer Drug. 2004;15:525–536.
17. H.Yuan, J.Miao, Y.Z.Du, J.You, F.Q.Hu, Z.Su Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm. 2008;348:137–145.
18. M.A.Schubert, C.C.Müller-Goymann Characterization of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm. 2005;61:77–86.
19. N.Schöler, E.Zimmermann, U.Katzfey, H.Hahn, R.H.Müller, O.Liesenfeld Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages. Int J Pharm. 2000;196:235–239.
20. N.Schöler, C.Olbrich, K.Tabatt, R.H.Müller, H.Hahn, O.Liesenfeld Surfactant but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int J Pharm. 2001;221:57–67.
21. R.H.Müller, S.Maassen, C.Schwarts, W.Mehnert Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes. J Control Release. 1997;47:261–269.
22. T.Yu, J.Lee, Y.G.Lee, S.E.Byeon, M.H.Kim, E.H.Sohn, Y.J.Lee, S.G.Lee, J.Youl. In vitro and in vivo anti-inflammatory effects of ethanol extract from Acer tegmentosum. J Ethnopharmacol. 2010;128(1):139–147.
23. S.A.Latt, G.Stetten Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis. J Histochem Cytochem. 1976;24:24–33.
24. D.R.Green, J.C.Reed Mitochondria and Apoptosis. Science. 1998;281:1309–1312.
25. M.O.Hengartner The biochemistry of apoptosis. Nature. 2000;407:770–776.
26. M.Tavassoli, J.Soltaninia, J.Rudnicka, D.Mashanyare, N.Johnson, J.Gäken Tamoxifen inhibits the growth of head and neck cancer cells and sensitizes these cells to cisplatin induced-apoptosis: role of TGF-b1. Carcinogenesis. 2002;23:1569–1575.
27. M.Clemons, S.Danson, A.Howell Tamoxifen (nolvadex): a review. Cancer Treat Rev. 2002;28:165–180.
28. P.E.Budtz Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen. Cell Prolif. 1999;32:289–302.
29. R.R.Perry, Y.Kang, B.Greaves Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann Surg Oncol. 1995;2:238–245.
30. G.Martin, G.Melito, E.Rivera Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea induced tumors. Cancer Lett. 1996;100:227–234.